Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7, 29

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy


Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy

Vito Pavone et al. Front Pharmacol.


CP is the most common cause of chronic disability in childhood occurring in 2-2.5/1000 births. It is a severe disorder and a significant number of patients present cognitive delay and difficulty in walking. The use of botulinum toxin (BTX) has become a popular treatment for CP especially for spastic and dystonic muscles while avoiding deformity and pain. Moreover, the combination of physiotherapy, casting, orthotics and injection of BTX may delay or decrease the need for surgical intervention while reserving single-event, multi-level surgery for fixed musculotendinous contractures and bony deformities in older children. This report highlights the utility of BTX in the treatment of cerebral palsy in children. We include techniques for administration, side effects, and possible resistance as well as specific use in the upper and lower limbs muscles.

Keywords: botulinum toxin A; cerebral palsy; key-muscle; multi-level treatment; resistance.

Similar articles

See all similar articles

Cited by 5 articles


    1. Alhusaini A. A., Crosbie J., Shepherd R. B., Dean C. M., Scheinberg A. (2011). No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy. Dev. Med. Child Neurol. 53, 553–558. 10.1111/j.1469-8749.2011.03930.x - DOI - PubMed
    1. Aoki K. R., Guyer B. (2001). Botulinum toxin type A and other botulinum toxin serotypes: acomparative review of biomechanical and pharmacological actions. Eur. J. Neurol. 8(Suppl. 5), 21–29. 10.1046/j.1468-1331.2001.00035.x - DOI - PubMed
    1. Arnon S. S., Schechter R., Inglesby T. V., Henderson D. A., Bartlett J. G., Ascher M. S., et al. . (2001). Botulinum toxin as a biologicalweapon: medical and public health management. JAMA 285, 1059–1070. 10.1001/jama.285.8.1059 - DOI - PubMed
    1. Beckung E., Hagberg G. (2002). Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev. Med. Child Neurol. 44, 309–316. 10.1111/j.1469-8749.2002.tb00816.x - DOI - PubMed
    1. Burke R. E., Fahn S., Marsden C. D., Bressman S. B., Moskowitz C., Friedman J. (1985). Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35, 73–77. 10.1212/WNL.35.1.73 - DOI - PubMed